Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4537-4543

  Devito, Nicholas ^a,b   Yu, Michael ^b   Chen, Ren ^a   Pan, Edward ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Brain metastases; Melanoma; Metastastic melanoma; Temozolomide; Whole brain radiation

Indexed keywords

CARBOPLATIN; CISPLATIN; DACARBAZINE; DASATINIB; DOCETAXEL; FLUDARABINE; PACLITAXEL; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 2; TEMOZOLOMIDE; VINBLASTINE;

ADULT; AGED; ALOPECIA; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CRANIOTOMY; DIARRHEA; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; LYMPHEDEMA; MALE; MELANOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PARESTHESIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING; WHOLE BRAIN RADIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84855161455     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Douglas JG and Margolin K: The treatment of brain metastases from malignant melanoma. Semin Oncol 29: 518-524, 2002. (Pubitemid 35178291)
2. Conill C, Jorcano S, Domingo-Doménech J, Gallego R, Malvehy J, Puig S, Sánchez M, Vilella R and Castel T: Whole-brain irradiation and temozolomide-based chemotherapy in melanoma brain metastases. Clin Transi Oncol 8: 266-270, 2006.
3. Stupp R, Mason WP, van den Bent MJ, Weiler M, Fisher B, Taphoom MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Caimcross JG, Eisenhauer E, Mirimanoff RO and the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
4. Patchell R: The treatment of brain metastases. Cancer Invest 14: 169-177, 1996.
5. Abrey LE and Christodoulou C: Temozolomide for treating brain metastases. Semin Oncol 25: 34-42, 2001. (Pubitemid 32879944)
6. Agarwala SS and Kirkwood JM: Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 5: 144-51, 2000.
7. Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN and Vlahos LJ: Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30: 361-366, 2007. (Pubitemid 47013372)
8. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA J Clin Cancer 60: 277-300, 2010.
9. Quirt I, Verma S, Petrella T, Bak K and Charette M: Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 12: 1114-1123, 2007. (Pubitemid 350007023)
10. Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P and Bedikian A: Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117: 1687-1696,2011.
11. Siena S, Crinò L, Danova M, Del Prete S, Cascinu S, Salvagni S, Schiavetto I, Vitali M and Bajetta E. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann Oncol 21: 655-661, 2010.
12. Morse HG, Moore GE, Ortiz LM, Gonzalez R and Robinson WA: Malignant melanoma: From subcutaneous nodule to brain metastasis. Cancer Genet Cytogenet 72: 16-23, 1994. (Pubitemid 24161922)
13. Middleton MR, Grab JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S, Gore M, Aamdal S, Cebon J, Coates A, Dreno B, Henz M, Schadendorf D, Kapp A, Weiss J, Fraass U, Statkevich P, Muller M and Thatcher N: Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18: 158-166, 2000. (Pubitemid 30036349)
14. Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F and Tyler DS: Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 15: 502-510, 2009.
15. Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R and Richmond A: Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Mol Cancer Ther 8: 636-647, 2009.
16. Khuntia D, Brown P, Li J and Mehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24: 1295-1304, 2006. (Pubitemid 46622033)
17. Shibamoto Y, Sugie C and Iwata H: Radiotherapy for metastatic brain tumors. Int J Clin Oncol 14: 281-288, 2009.
18. Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, Clark I, Weiss G, Sosman J, II Smith W, Dutcher P, Gollob J, Longmate J and Johnson D: Temozolomide and whole-brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 128: 214-218, 2002. (Pubitemid 34280379)
19. Atkins MB, Sosman JA, Agarwala S, Logan T, Clark JI, Ernstoff MS, Lawson D, Dutcher JP, Weiss G, Curti B, Margolin KA: Temozolomide, thalidomide, and whole-brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. Cancer 113: 2139-2145, 2008.
20. Tsao MN, Lloyd NS and Wong RK: Clinical practice guidelines on the optimal radiotherapeutic management of brain metastases. BMC Cancer 5: 34, 2005.
21. Samlowski WE, Jensen RL and Shrieve DC: Multimodality management of brain metastases in metastatic melanoma patients. Expert Rev Anticancer Ther 7: 1699-1705, 2007. (Pubitemid 350303000)
22. Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, Rowland KM Jr. and Bearden JD: Brain metastases from melanoma: Is there a role for concurrent temozolomide in addition to whole-brain radiation therapy? Am J Clin Oncol 33: 633-636, 2010.
23. Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B, Atkins M, Buzaid A, Skarlos D and Rankin EM: Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22: 2101-2107, 2004. (Pubitemid 41095143)
24. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS and Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494-500, 1990. (Pubitemid 20067825)
25. Hart MG, Grant R, Walker M and Dickinson HO: Surgical resection and whole brain radiation therapy versus whole-brain radiation therapy alone for single brain metastases. Cochrane Database Syst Rev 25(1): CD003292, 2005.